Table1.
Variables | HR(95%CI) | P value |
---|---|---|
Univariate analysis | ||
Gender (M vs F)a | 1.440(0.975–2.128) | 0.067 |
Age(years)(<60 vs ≥60) | 0. 955(0.643–1.418) | 0.818 |
Location (C/B vs A/W)b | 0.826(0.556–1.228) | 0.345 |
Tumor size (cm in diameter)(>5.5 vs ≤5.5) | 1.707(1.127–1.945) | 0.007 |
Vascular invasion (yes vs no) | 1.481(0.671–2.155) | 0.005 |
Histological stage (P/U vs W/M)c | 2.121(1.259–3.573) | 0.005 |
AJCC stage (I/II vs III/IV) | 4.559(2.845–7.306) | <0.001 |
T stage (T1/T2 vs T3/T4) | 3.632(1.761–7.492) | <0.001 |
N stage (N0 vs N1~ 3) | 3.992(2.224–7.166) | <0.001 |
M stage (M0 vs M1) | 2.613(1.379–4.952) | 0.003 |
Hsp90ab1 expression (low vs high) | 2.525(1.457–4.377) | 0.001 |
Multivariate analysis | ||
AJCC stage (I/II vs III/IV) | 4.166(2.573–6.746) | <0.001 |
Vascular invasion (yes vs no) | 1.524(1.177–1.974) | 0.001 |
Hsp90ab1 expression (low vs high) | 1.983(1.130–3.478) | 0.017 |
HR hazard ratio, CI confidence interval
*Statistically significant (P < 0.05)
aM male, F female
bC cardia, B body, A antrum, W whole
cP poor, U undifferentiated, W well, M moderate